UNIMED (同心智医)

Beijing, China

AI / ML Neurology Diagnostics Treatment & Therapeutics

UNIMED (同心智医) is a developer of a new generation of AI brain science diagnosis and treatment platform. Relying on advanced medical technology, Internet technology and artificial intelligence technology, the company has successfully launched the innovative AI algorithm of "cause and effect inference" through years of resource collection and data precipitation.

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out UNIMED (同心智医) on @MedStartr Today #BrainHealth #NeurologicalDisorders #Neuroscience #AIML #Neurology #Diagnostics #TreatmentTherapeutics #MedMo #MedStartrVentures

https://www.medstartr.ai/s/lTF0bgDyCQI

Get Involved in UNIMED (同心智医)

🏢Is this your company? Claim This Profile

Join MedStartr to verify with your work email and edit this profile

Company Info

Founded: 2014
Website: www.tongxinzhiyi.cn/

Disease Areas

Brain Health Neurological Disorders Neuroscience

Technologies

AI/Machine LearningAI-native PlatformDiagnostic PlatformsBrain-Computer Interface (BCI)

🌐Website

What do you think of UNIMED (同心智医)?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.